申请人:Vertex Pharmaceuticals Incorporated
公开号:US05723459A1
公开(公告)日:1998-03-03
The present invention relates to novel compounds which possess a broad range of useful biological activities. These compounds can maintain, increase, or restore sensitivity of cells to therapeutic or prophylactic agents. They can also suppress, modify, or significantly reduce an immune response, including an autoimmune response in a mammal. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well-suited for treatment of multi-drug resistant cells, for prevention of the development of multi-drug resistance, for use in multi-drug resistant cancer therapy, and for prevention or treatment of graft rejection and various autoimmune diseases.
本发明涉及具有广泛有用生物活性的新化合物。这些化合物可以维持、增加或恢复细胞对治疗或预防药物的敏感性。它们还可以抑制、改变或显著减少哺乳动物体内的免疫反应,包括自身免疫反应。本发明还涉及包含这些化合物的药物组合物。本发明的化合物和药物组合物特别适用于治疗多药耐药细胞,预防多药耐药性的发展,用于多药耐药性癌症治疗,以及预防或治疗移植排斥和各种自身免疫疾病。